Torbay Pharmaceuticals, a part of the Torbay and South Devon National Health System Foundation, opened its new $36 million manufacturing facility in Paignton,…
Thousands of FDA employees will get a reprieve instead of pink slips next week as FDA Commissioner Scott Gottlieb gave them encouraging job news.
With the expanding definition of “health” in play, does the category warrant a separate show in a program like the Lions?
German drugmaker Boehringer Ingelheim will invest $217 million to upgrade and expand its Fremont, California, facility to boost production.
BiodVax will test its universal flu vaccine candidate M-001 as a standalone shot after it elicited positive immune responses as a primer in a phase 2b trial.
More uncertainty has roiled Teva, as the company indicated it would eliminate up to 350 production workers in Israel.
Endo has decided the 350 jobs it whacked from its Huntsville, Alabama, manufacturing site were not enough and will close it instead.
Corning, with input from Pfizer and Merck, intends to build a $500 million plant in the U.S. to produce a new pharma glass.
Australia’s TPI Enterprises has struck a deal to buy the opioid and CMO tablet businesses of Norway’s Vistin Pharma.
The FDA has slapped an Italian sterile manufacturer with a warning letter pointing to the contamination hazards tied to its highly manual processes.
GlaxoSmithKline plans to unload some marginal businesses and make other cuts that it says will cost about 320 manufacturing jobs in its home country.